About Us

Contact Us

Race
Home About Us Product News Order Career Contact

                                                                                                            

           APIs&Intermediates Chemicals of Shanghai APIs Chemical Co., Ltd 

           

Product Indentification
 

Name:   Crizotinib
Synonyms:   PF-02341066
CAS Registry Number:   877399-52-5
Molecular Formula:   C21H22Cl2FN5O
Molecular Weight:    450.34
Molecular Structure:  

 

                                      3D structure

 


                    In stock! Bulk!

 

 

                   Purity:99%min

 

 

                   ee: 99%

 

 

                   Storage: -20 deg C for 2 years

 

 

                   Inquiry

 

 

 

Related products:

 

            877399-74-1|tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate

            877397-65-4|(S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol

            PF-02341066|877399-52-5 

 

 

Related c-Met Inhibitors:

 

 

          AMG-208|1002304-34-8                                                                  Axitinib|319460-85-0   

 

         Foretinib|849217-64-7                                                                    JNJ-38877605|943540-75-8   

  

          MGCD-265|875337-44-3                                                               PF-04217903|956905-27-4

         
SGX-523|1022150-57-7                                                                  SU11274|658084-23-2

 

      849217-68-1|Cabozantinib                                                              PF-02341066|877399-52-5

 

      1000873-98-2|ARQ197

 

 

Related pages:


     Search PF-02341066 or Crizotinib in google
     Search CAS 877399-52-5  in google
     Search C21H22Cl2FN5O  in google

 

Related info:

 

       Crizotinib (Xalkori,Pfizer), is an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene1, receptor tyrosine kinase) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumors in both adults and children.

 

 

 

 

Human anaplastic lymphoma kinase in complex with crizotinib [From wiki]

 

 

 

Home About Us Product News Order Career Contact
 Copyright @ 2010-2011 APIs All rights reserved
 

 

 

No_Right_Click

 

No_Right_Click